Jagsonpal Pharmaceuticals Ltd - JAGSONPAL PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE048B01027
₹ 293.55 (-0.99%) icon12 Apr, 2024, 12:00:00 AM
Open
₹ 294.00
Prev. Close
₹ 296.50
Turnover(lac)
₹ 0.00
Day's High
₹ 299.80
Day's Low
₹ 290.70
52 Wk High
₹ 514.85
52 Wk Low
₹ 273.60
Book Value
₹ 67.30
Face Value
₹ 5.00
Mkt. Cap (Cr.)
₹ 776.08
P/E
31.97
EPS
9.27
Div. Yield
1.67

Jagsonpal Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/12/2024 12:00:00 AM

    ₹ 293.55 -2.95 -0.99
  • Open
  • ₹ 294
  • Prev. Close
  • ₹ 296.5
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 299.8
  • Day's Low
  • ₹ 290.7
  • 52 Week's High
  • ₹ 514.85
  • 52 Week's Low
  • ₹ 273.6
  • Book Value
  • ₹ 67.3
  • Face Value
  • ₹ 5
  • Mkt Cap (₹ Cr.)
  • 776.08
  • P/E
  • 31.97
  • EPS
  • 9.27
  • Divi. Yield
  • 1.67

Jagsonpal Pharmaceuticals Ltd Corporate Actions

25 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2024

12:00 AM

26 Oct , 2023

12:00 AM

26 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Aug , 2023

12:00 AM

AGM

Announcement date: 05 Aug , 2023

View Details

23 May , 2023

12:00 AM

Dividend

Dividend amount: 5
Announcement date: 23 May , 2023

View Details

25 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jul , 2023

12:00 AM

15 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

No Record Found


Jagsonpal Pharmaceuticals Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Jagsonpal Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
12 April , 2024 | 05:39 PM

PROMOTER - TOTAL68.48%

Indian: 24.90%

Foreign: 43.5773%

NON-PROMOTER - TOTAL 31.52%

Institutions: 1.35%

Non-Institutions: 30.17%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Jagsonpal Pharmaceuticals Ltd FINANCIALS

No Data Available To Display Chart

Jagsonpal Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Jagsonpal Pharmaceuticals Ltd

  • Manish Gupta
  • Managing Director
  • Harsha Raghavan
  • Chairman & Non Executive Dir.
  • Debasis Bikash Nandy
  • Independent Director
  • Radhika Dudhat
  • Independent Director
  • Pallavi Dinodia
  • Independent Director
  • Prithipal Singh Kochhar
  • Non Executive Director
  • Abhishek Joshi
  • Company Sec. & Compli. Officer

Summary

Promoted by J S Kochhar in 1978, Jagsonpal Pharmaceuticals is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India. It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company.The Companys R&D activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. Its R&D activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia.In the fiscal 2001, the companys sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from... Read More


Reports by Jagsonpal Pharmaceuticals Ltd


Reports by Jagsonpal Pharmaceuticals Ltd

Company FAQ

No Record Found